Read more about the article Albert Labs’ Pre-Clinical Analytical and Toxicological Research Supports Company’s Forthcoming Studies

Albert Labs’ Pre-Clinical Analytical and Toxicological Research Supports Company’s Forthcoming Studies

Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.

Continue ReadingAlbert Labs’ Pre-Clinical Analytical and Toxicological Research Supports Company’s Forthcoming Studies
Read more about the article Albert Labs adds natural drug development expert Prof. Rob Britton to its scientific advisory team

Albert Labs adds natural drug development expert Prof. Rob Britton to its scientific advisory team

Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.

Continue ReadingAlbert Labs adds natural drug development expert Prof. Rob Britton to its scientific advisory team
Read more about the article Albert Labs adds toxicology expert Dr. Ricardo Dinis-Oliveira to its scientific advisory team

Albert Labs adds toxicology expert Dr. Ricardo Dinis-Oliveira to its scientific advisory team

Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.

Continue ReadingAlbert Labs adds toxicology expert Dr. Ricardo Dinis-Oliveira to its scientific advisory team
Read more about the article Albert Labs Announces the Addition of Two Renowned Scientific Advisors to its Scientific Advisory Board (SAB)

Albert Labs Announces the Addition of Two Renowned Scientific Advisors to its Scientific Advisory Board (SAB)

Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.

Continue ReadingAlbert Labs Announces the Addition of Two Renowned Scientific Advisors to its Scientific Advisory Board (SAB)
Read more about the article Imperial College study on psilocybin for depression highlights need for Real-World Evidence trials

Imperial College study on psilocybin for depression highlights need for Real-World Evidence trials

Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.

Continue ReadingImperial College study on psilocybin for depression highlights need for Real-World Evidence trials